Clonal tracking and molecular characterization of hematopoiesis under stress
Clonal tracking and molecular characterization of hematopoiesis under stress
批准号:
10413504
负责人:
David T Scadden
金额:
$5.04万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-15 至 2023-03-31
关键词:
AddressAgeAnimal ModelBehaviorBlood CellsBlood Flow CytometryBone MarrowCRISPR screenCellsCharacteristicsClonal ExpansionClonal Hematopoietic Stem CellClone CellsCollectionDataDevelopmentDisadvantagedDiseaseDysmyelopoietic SyndromesEngineeringEpigenetic ProcessEquilibriumFluorescenceFrequenciesGene ExpressionGene Expression ProfileGene Expression ProfilingGeneticGenotoxic StressGoalsHabitsHematological DiseaseHematologyHematopoiesisHematopoieticHematopoietic stem cellsHeterogeneityHumanIndividualInflammatoryInterventionKineticsLabelLaboratoriesLesionLymphoidMethodsMolecularMolecular AnalysisMolecular ProfilingMusMutationMyelogenousNeoplasmsNormal CellPhenotypePopulationProductionRadiationRegulator GenesResearchResolutionRetrotransposonRiskStimulusStressSystemTechniquesTestingTimeTransplantationZebrafishbasecollaborative approachcomparativegenotoxicityimprovedin vivoinsightmortalitymutantnoveloffspringpremalignantprimitive cellprogenitorresponsesmall hairpin RNAstem cells
中文摘要
研究综述
造血现在被认为是多个,主要是祖细胞克隆的综合活动,具有
异质行为。克隆的复杂性被认为随着年龄的增长而减少,人类研究表明
带有疾病相关突变的寡克隆性造血是常见的。这种克隆的存在会招致
有很大的血液肿瘤风险,所有这些都会导致死亡。这项提案的总体目标是
了解应激条件下克隆行为的分子驱动因素,并测试是否修改
这些驱动力能够改变正常和非正常、承担风险的相对竞争平衡
动物模型中的克隆。我们将在我们开发的小鼠中使用荧光克隆跟踪技术
并将其与Carmago和Carmago小鼠的逆转录转座子克隆标记技术进行比较。
Zon开发的斑马鱼荧光克隆示踪技术。此外,我们还将描述
用Tenen和Defined ncRNA技术研究单细胞分辨率克隆的遗传特征
Tenen的候选分子驱动器。最后,我们将针对由田纳西州Orkin定义的表观遗传修饰
和Zon在体内测试对正常克隆和突变克隆之间克隆竞争的影响。将这些组合在一起
互补和协作的方法将指向改变竞争关系的方法
有利于正常细胞的造血。
英文摘要
RESEARCH SUMMARY
Hematopoiesis is now recognized as the integrated activity of multiple, largely progenitor clones with
heterogeneous behavior. Clonal complexity is thought to diminish with age and human studies suggest that
oligoclonal hematopoiesis with disease associated mutations is common. The presence of such clones incurs
a substantial risk of hematologic neoplasia and all cause mortality. The overall goal of this proposal is to
understand the molecular drivers of clonal behavior under stress conditions and to test whether modifying
those drivers is capable of changing the relative competitive balance of normal and abnormal, risk bearing
clones in animal models. We will use techniques of fluouresence clonal tracking in the mouse developed by us
and compare these with retrotransposon clonal marking techniques in the mouse of Carmago and
fluorescence clonal tracking techniques in the zebrafish developed by Zon. Further, we will characterize
genetic characteristics of clones at single cell resolution using techniques of Tenen and define ncRNA
candidate molecular drivers with Tenen. Finally, we will target epigenetic modifiers defined by Orkin, Tenen
and Zon to test the impact on clonal competition between normal and mutant clones in vivo. Combined these
complementary and collaborative approaches will point to methods for altering competitive relationships in
hematopoiesis in favor of normal cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional consequences of stem and progenitor cell heterogeneity
-
批准号:10413502
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Enhancing regeneration of stem cell-derived HIV-specific immune effectors
-
批准号:10409803
-
项目类别:
-
资助金额:$55.27万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Enhancing regeneration of stem cell-derived HIV-specific immune effectors
-
批准号:10163909
-
项目类别:
-
资助金额:$49.97万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Functional consequences of stem and progenitor cell heterogeneity
-
批准号:10188996
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Enhancing regeneration of stem cell-derived HIV-specific immune effectors
-
批准号:10601073
-
项目类别:
-
资助金额:$58.87万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Project 1: Implications of blood cell heterogeneity for CV disease
-
批准号:10238040
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2019
-
负责人:David T Scadden
-
依托单位:
Project 1: Implications of blood cell heterogeneity for CV disease
-
批准号:10469350
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2019
-
负责人:David T Scadden
-
依托单位:
Project 1: Implications of blood cell heterogeneity for CV disease
-
批准号:10670732
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2019
-
负责人:David T Scadden
-
依托单位:
Functional consequences of stem and progenitor cell heterogeneity
-
批准号:10641537
-
项目类别:
-
资助金额:$261.17万
-
财政年份:2017
-
负责人:David T Scadden
-
依托单位:
Administrative Core
-
批准号:10641538
-
项目类别:
-
资助金额:$2.58万
-
财政年份:2017
-
负责人:David T Scadden
-
依托单位:
Project 2 - Cell of origin contributions and vulnerabilities in clonal hematopoiesis
-
批准号:10641541
-
项目类别:
-
资助金额:$50.99万
-
财政年份:2017
-
负责人:David T Scadden
-
依托单位:
In vivo tracking of the hematopoietic stem cell clonal dynamics using a novel multi-fluorescent transgenic mouse model
-
批准号:9134179
-
项目类别:
-
资助金额:$23.95万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
Cell and Molecular Dynamics of Hematopoiesis In Vivo
-
批准号:9527128
-
项目类别:
-
资助金额:$73.96万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
CORE A: Administrative and Biostatisitcs Core
-
批准号:8897536
-
项目类别:
-
资助金额:$14.37万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
In vivo tracking of the hematopoietic stem cell clonal dynamics using a novel multi-fluorescent transgenic mouse model
-
批准号:8969345
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia
-
批准号:8866712
-
项目类别:
-
资助金额:$51.05万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
A defend and destroy approach to curing HIV
-
批准号:9254596
-
项目类别:
-
资助金额:$228.57万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
Cell and Molecular Dynamics of Hematopoiesis In Vivo
-
批准号:9312803
-
项目类别:
-
资助金额:$76.19万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
Mechanisms of Hematopoiesis in AIDS
-
批准号:8528891
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2012
-
负责人:David T Scadden
-
依托单位:
Bone Microenvironment Contributions to Metastatic Disease
-
批准号:8933402
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2011
-
负责人:David T Scadden
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: